Encouraging results from ProQR USH2A clinical trial
Biotechnology company ProQR has announced encouraging results from its phase 1/2 clinical trial of an innovative treatment for sight loss caused by faults in a specific section of the USH2A gene.
Search
Search results
Types of inherited sight loss
Inherited progressive sight loss is caused by a range of rare genetic conditions. We specialise in those which affect the retina.
Research grant awards worth £870K announced
Retina UK is delighted to announce that it has awarded three new research grants worth more than £870,000.
Webinar: Miles for Vision: Behind the Scenes of the London Marathon 2025
The latest webinar from Retina UK.
Tough Mudder 2025
With various events to choose from in 2025, these hugely popular events are back for another year! Round up your friends, family members and colleagues and join #TeamRetinaUK for a fun day out!
Inflatable Assault Courses 2025
With various events to choose from in 2025, these hugely popular events are back for another year! Round up your friends, family members and colleagues and join #TeamRetinaUK for a fun day out!
Medical research
Retina UK has invested more than £16million into cutting-edge research since the charity was founded in 1976.
Bungee Jumping
With various locations to choose from in 2025, these hugely popular jumps are back for another year! Join #TeamRetinaUK for a fun day out in 2025.
New ‘vision’ and identity sight loss charities
The collective partnership of eight of the leading charities in the sight loss sector, known for the last three years as the VI Charity Sector Partnership, has re-launched under a new identity of the ‘Vision Partnership’ with a re-invigorated purpose and new strategic focus.